Interestingly miR-214-3p, which was decreased upon RAPA treatment in DM + I/R, was predicted to target Autophagy Related 12 (ATG12), Myocyte Enhancer Factor 2C (MEF2C), PTEN, PPARGC1B, and MAPK1. This evidence concerns the gene PTEN and diabetes mellitus.